Search


State of Possible: Strand Therapeutics' Co-Founder & CEO Jake Becraft talks mRNA and getting into the clinic with the company's first program
He describes the intratumoral IL-12 program that is in the clinic today, and the preclinical progress Strand is making on its other...
Mar 26


The next generation of mRNA beyond vaccines with Strand Therapeutics
Jake Becraft describes emerging new techniques in using mRNA and gives BiotechTV a tour of Strand’s Fenway HQ to show us the R&D process.
Sep 5, 2023